bioRxivPharmacology & ToxicologyPreprint
Comparative Proteomics Reveals Characteristic Proteins on Praziquantel-resistance in Schistosoma mansoni
António Pinto-AlmeidaiD, Tiago Mendes, Pedro Ferreira, Silvana Belo, Fernanda de Freitas Anibal, Silmara Marques Allegretti, Emanuel Carrilho, Ana Afonso
Abstract
The extensive use of Praziquantel (PZQ), the only drug available to treat schistosomiasis, has brought concern about the emergence of PZQ-resistance/tolerance by Schistosoma spp., thus reaffirming an urge for the development of new treatment alternatives. Therefore, it is imperative and urgent to study this phenomenon trying to understand what is involved in its occurrence. Studies of Schistosoma spp. genome, transcriptome and proteome are crucial to better understand this situation. By stepwise drug pressure from a fully susceptible parasite strain, our group selected a S. mansoni variant strain stably resistant to PZQ and isogenic to its fully susceptible parental counterpart, except for the genetic determinants of PZQ-resistance phenotype. Based on this, the objective of this study was to compare the proteomes of both strains, identifying proteins from male and female adult worms of PZQ-resistant and PZQ-susceptible strains, exposed and not exposed to PZQ, which were separated by high-resolution two-dimensional electrophoresis and sequenced by high throughput LC-MS/MS. Likewise, this work is extremely relevant since for the first time the proteome of a S. mansoni PZQ-resistant strain is studied and compared to the proteome of the respective S. mansoni PZQ-susceptible strain. This study identified 60 S. mansoni proteins, some of which differentially expressed in either strain, which may putatively be involved in the PZQ-resistance phenomenon. This information represents substantial progress towards deciphering the worm proteome. Furthermore, these data may constitute an informative source for further investigations into PZQ-resistance and increase the possibility of identifying proteins related to this condition, possibly contributing to avoid or decrease the likelihood of development and spread of PZQ-resistance. This is an innovative study that opens doors to PZQ-resistance surveys, contributing to discover a solution to PZQ-resistance problem, as suggests new potential targets for study.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Direct measurement of in vitro response to Praziquantel in Schistosoma mansoni populations from Western Kenya
Eric M. Ndombi, John K. Oguso, … Timothy J. C. Anderson·bioRxiv·Jul 22, 2026
- Genetic analysis of praziquantel response in schistosome parasites implicates a Transient Receptor Potential channel
Winka Le Clecʼh, Frédéric D. Chevalier, … Timothy J. C. Anderson·Science Translational MedicinePeer-reviewed·Dec 22, 2021
- Extensive transmission and variation in a functional receptor for praziquantel resistance in endemic Schistosoma mansoni
Duncan Berger, Sang-Kyu Park, … Joanne P. Webster·bioRxiv·Aug 29, 2024
- Pooled amplicon sequencing for characterizing mutations in the praziquantel molecular target TRPMPZQ in schistosome populations from Western Kenya
Peter Olilah, Frédéric D. Chevalier, … Eric M. Ndombi·bioRxiv·Aug 9, 2026
- Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis
S. N. Alwan, A. B. Taylor, … P. T. LoVerde·bioRxiv·May 23, 2023
- Small change, big difference: A novel praziquantel derivative P96 with multistage antischistosomal activity for chemotherapy of schistosomiasis japonica
J. Xu, L.-L. Dong, … C.-M. Xia·bioRxiv·Mar 6, 2023